Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tongchuanqing Granule
- Development stage
- Unknown
- Lead developer
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Tongchuanqing Granule is a Traditional Chinese Medicine (TCM) hospital preparation developed by the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. It is primarily indicated for the treatment of bronchial asthma, particularly during the remission or chronic persistent stages. The formulation is designed based on TCM principles to ventilate the lungs, resolve phlegm, and relieve wheezing. Clinical studies have suggested its efficacy in improving lung function and reducing the frequency of asthma exacerbations by modulating the immune response. Specifically, it has been shown to regulate the Th1/Th2 cytokine balance by decreasing levels of pro-inflammatory cytokines such as Interleukin-4 (IL-4) and Interleukin-5 (IL-5) while increasing levels of Interferon-gamma (IFN-gamma). As a hospital preparation, its use is currently authorized within the developing institution in Tianjin, China.
- Brand names
- Tongchuanqing Granule
- Other names
- Tongchuanqing KeliTCQ
02
Targets
IL-4 (Interleukin 4)IL-5 (Interleukin 5)IFNG (Interferon gamma)
Beyond the preview
Go deeper on Tongchuanqing Granule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tongchuanqing Granule.